"Clarity is a form of care," said Arlee Riveland, CEO and Co-Founder. "I didn't set out to found a healthcare company, but I did set out to build human-centered tools that solve real problems. And this one matters."

Addressing Critical Access Gaps

Craft Telemedicine launches with high-quality compounded medications, beginning with Low-Dose Naltrexone and Methylene Blue—specialized treatments often difficult to access through traditional healthcare channels.

"When patients search for Methylene Blue online, they're flooded with options that range from aquarium treatments to industrial dyes," said Jack Korbutov, Co-Founder and pharmacist at The Art of Medicine. "Many people don't realize that what they're buying isn't pharmaceutical-grade and heavy metal-free. This could actually be harmful."

The platform was built in partnership with The Art of Medicine to ensure patients receive pharmaceutical-grade compounded medications with rigorous quality standards. The founding team includes Stephen Stearman, who brings extensive healthcare entrepreneurship experience through his leadership of multiple healthcare companies under the Craft Health Group.

Expanding Nationwide Network

Craft Telemedicine is actively seeking partnerships with high-quality compounding pharmacies nationwide, positioning itself as the preferred telemedicine platform for pharmacies seeking to grow their patient base without compromising their values or independence.

"We're building a network of trusted compounding pharmacies that share our commitment to quality and patient care," explained Riveland. "We're not just delivering prescriptions—we're restoring agency to patients."

The platform is currently available in 25 states with plans to serve all 50 states by 2026. Patients can access the platform at crafttelemed.com with transparent, pay-per-prescription pricing and no subscription fees.

Company Contact: Arlee Riveland, CEO & Co-Founder
Email: [email protected]
Website: crafttelemed.com

SOURCE Craft Telemedicine